|
OCLN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.664190E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.990800E-01 |
| Normal-vs-Stage2 |
1.721200E-01 |
| Normal-vs-Stage3 |
1.604020E-01 |
| Normal-vs-Stage4 |
3.005200E-04 |
| Stage1-vs-Stage2 |
5.038600E-01 |
| Stage1-vs-Stage3 |
3.703600E-01 |
| Stage1-vs-Stage4 |
2.171500E-04 |
| Stage2-vs-Stage3 |
9.097600E-01 |
| Stage2-vs-Stage4 |
6.667500E-02 |
| Stage3-vs-Stage4 |
1.152600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.622400E-01 |
| Normal-vs-AfricanAmerican |
1.384090E-02 |
| Normal-vs-Asian |
4.861300E-03 |
| Caucasian-vs-AfricanAmerican |
3.831700E-02 |
| Caucasian-vs-Asian |
1.834430E-02 |
| AfricanAmerican-vs-Asian |
1.877420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.548830E-01 |
| Normal-vs-Female |
4.041000E-01 |
| Male-vs-Female |
7.750000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.266400E-02 |
| Normal-vs-Extreme_Weight |
3.403200E-01 |
| Normal-vs-Obese |
4.140400E-01 |
| Normal-vs-Extreme_Obese |
4.894100E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.750400E-01 |
| Normal_Weight-vs-Obese |
1.795410E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.792000E-01 |
| Extreme_Weight-vs-Obese |
8.783800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.660800E-01 |
| Obese-vs-Extreme_Obese |
3.318400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.796100E-02 |
| Normal-vs-Age(41-60Yrs) |
8.815600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.196200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.642580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.466000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.149200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.804800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.635610E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.918380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.138800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.937200E-01 |
| Normal-VS-Type2 PRCC |
3.048200E-04 |
| Normal-VS-KIRP CIMP |
4.803600E-03 |
| Normal-VS-Unclassified PRCC |
6.433400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.76239999999784E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.475670E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.885600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.727000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.538100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.217500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.043000E-03 |
| Normal-vs-N1 |
1.889900E-02 |
| Normal-vs-N2 |
4.066100E-02 |
| N0-vs-N1 |
7.655600E-01 |
| N0-vs-N2 |
7.356600E-01 |
| N1-vs-N2 |
5.862800E-01 |
|
|
